Bliss GVS Pharma Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Small Cap

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2024.

Powered by Capital Market - Live News

Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will be held on 25 July 2024.

Powered by Capital Market - Live News

Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 2 May 2024, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Net loss of Bliss GVS Pharma reported to Rs 9.15 crore in the quarter ended March 2024 as against net profit of Rs 3.34 crore during the previous quarter ended March 2023. Sales rose 7.22% to Rs 198.13 crore in the quarter ended March 2024 as against Rs 184.78 crore during the previous quarter ended March 2023.

For the full year,net profit rose 6.48% to Rs 75.45 crore in the year ended March 2024 as against Rs 70.86 crore during the previous year ended March 2023. Sales rose 2.48% to Rs 770.24 crore in the year ended March 2024 as against Rs 751.59 crore during the previous year ended March 2023.

Powered by Capital Market - Live News